Plus Therapeutics (FRA:XMP1) FFO


FRA:XMP1 Plus Therapeutics Inc FRA:XMP1
22 GF Score
Price €3.49
! 2 Warning Signs
View Full Analysis

What is Plus Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:XMP1
22GF Score
Plus Therapeutics Inc FRA:XMP1
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Plus Therapeutics Business Description

Other Exchanges PSTV:USA
Address 6420 Levit Green Boulevard, Suite 210, Houston, TX, USA, 77021
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
22GF Score

Get the complete analysis for FRA:XMP1

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.49
Price